Riesgo cardiovascular evaluado mediante el índice tobillo-brazo en pacientes con síndrome metabólico de diagnóstico reciente

Background: Patients with altered ankle-arm index have risk of cardiovascular events in the next 10 years (cerebral or cardiac infarction). It is known that the glycosylated hemoglobin and each of the components of the metabolic syndrome increases the cardiovascular risk. Material and methods: We performed a cross-sectional, multicenter, population-based study in 105 individuals with metabolic syndrome recently diagnosis in four primary care centers in Mexico City. The cardiovascular risk was evaluated using ankle-arm index. results: We studied 105 patients. The linear correlation analysis showed simple factor of increased risk (odds ratio [OR] 3.9 [95% CI: 1.05 -14.31]) with glycosylated hemoglobin 6.5 or 7 there was no statistically significant difference. Correlation of the mean arterial pressure (MAP) with the ankle-arm index: OR 7.2 for mean arterial blood pressure > 88 mm Hg OR: 5.6 (95% CI: 1.43 23.45) and with mean arterial pressure > 100 mm Hg. Conclusions: Cardiovascular risk increases if the glycosylated hemoglobin is less than 6.5 %, or if the mean arterial pressure is greater than 88 mm Hg, in patients with newly diagnosed metabolic syndrome.